10 results on '"Gbadegesin, Rasheed A"'
Search Results
2. Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study.
- Author
-
Maniar, Aesha, Gipson, Debbie S., Brady, Tammy, Srivastava, Tarak, Selewski, David T., Greenbaum, Larry A., Dell, Katherine M., Kaskel, Frederick, Massengill, Susan, Tran, Cheryl, Trachtman, Howard, Lafayette, Richard, Almaani, Salem, Hingorani, Sangeeta, Wang, Chia-shi, Reidy, Kimberly, Cara-Fuentes, Gabriel, Gbadegesin, Rasheed, Myers, Kevin, and Sethna, Christine B.
- Subjects
STEROIDS ,DATA analysis ,SCIENTIFIC observation ,SEX distribution ,DESCRIPTIVE statistics ,AGE distribution ,RITUXIMAB ,NEPHROTIC syndrome ,LONGITUDINAL method ,RESEARCH ,STATISTICS ,GROWTH disorders ,ANTHROPOMETRY ,COMPARATIVE studies ,CONFIDENCE intervals ,REGRESSION analysis ,GLOMERULAR filtration rate ,DISEASE incidence ,CHILDREN - Abstract
Background: Steroids, the mainstay of treatment for nephrotic syndrome in children, have multiple adverse effects including growth suppression. Methods: Anthropometric measurements in children < 18 years enrolled in the Nephrotic Syndrome Study Network (NEPTUNE) were collected. The longitudinal association of medication exposure and nephrotic syndrome characteristics with height z-score and growth velocity was determined using adjusted Generalized Estimating Equation regression and linear regression. Results: A total of 318 children (57.2% males) with a baseline age of 7.64 ± 5.04 years were analyzed. The cumulative steroid dose was 216.4 (IQR 61.5, 652.7) mg/kg (N = 233). Overall, height z-scores were not significantly different at the last follow-up compared to baseline (− 0.13 ± 1.21 vs. − 0.23 ± 1.71, p = 0.21). In models adjusted for age, sex, and eGFR, greater cumulative steroid exposure (β − 7.5 × 10
−6 , CI − 1.2 × 10−5 , − 3 × 10−6 , p = 0.001) and incident cases of NS (vs. prevalent) (β − 1.1, CI − 2.22, − 0.11, p = 0.03) were significantly associated with lower height z-scores over time. Rituximab exposure was associated with higher height z-scores (β 0.16, CI 0.04, 0.29, p = 0.01) over time. Conclusion: Steroid dose was associated with lower height z-score, while rituximab use was associated with higher height z-score. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
3. Population Pharmacokinetics of Caffeine in Neonates with Congenital Heart Disease and Associations with Acute Kidney Injury.
- Author
-
Thompson, Elizabeth J., Zimmerman, Kanecia O., Gonzalez, Daniel, Foote, Henry P., Park, Sangah, Hill, Kevin D., Hurst, Jillian H., Hornik, Chi D., Chamberlain, Reid C., Gbadegesin, Rasheed A., and Hornik, Christoph P.
- Subjects
ACUTE kidney failure prevention ,CARDIAC surgery ,MULTIVARIATE analysis ,TIME ,CONGENITAL heart disease ,RETROSPECTIVE studies ,ACQUISITION of data ,COMPARATIVE studies ,CAFFEINE ,MEDICAL records ,RESEARCH funding ,CARDIOPULMONARY bypass ,PREDICTION models ,LOGISTIC regression analysis ,LONGITUDINAL method ,CHILDREN - Abstract
Cardiac surgery‐associated acute kidney injury (CS‐AKI) occurs in approximately 65% of neonates undergoing cardiac surgery on cardiopulmonary bypass and contributes to morbidity and mortality. Caffeine may reduce CS‐AKI by counteracting adenosine receptor upregulation after bypass, but pharmacokinetics (PK) in this population are unknown. The goal of our analysis is to address knowledge gaps in age‐, disease‐, and bypass‐related effects on caffeine disposition and explore preliminary associations between caffeine exposure and CS‐AKI using population PK modeling techniques and an opportunistic, electronic health record‐integrated trial design. We prospectively enrolled neonates receiving preoperative caffeine per standard of care and collected PK samples. We retrospectively identified neonates without caffeine exposure undergoing surgery on bypass as a control cohort. We followed US Food and Drug Administration guidance for population PK model development using NONMEM. Effects of clinical covariates on PK parameters were evaluated. We simulated perioperative exposures and used multivariable logistic regression to evaluate the association between caffeine exposure and CS‐AKI. Twenty‐seven neonates were included in model development. A 1‐compartment model with bypass time as a covariate on clearance and volume of distribution best fit the data. Twenty‐three neonates with caffeine exposure and 109 controls were included in the exposure‐response analysis. Over half of neonates developed CS‐AKI. On multivariable analysis, there were no significant differences between CS‐AKI with and without caffeine exposure. Neonates with single‐ventricle heart disease without CS‐AKI had consistently higher simulated caffeine exposures. Our results highlight areas for further study to better understand disease‐ and bypass‐specific effects on drug disposition and identify populations where caffeine may be beneficial. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study
- Author
-
Zahr, Rima S., Yee, Marianne E., Weaver, Jack, Twombley, Katherine, Matar, Raed Bou, Aviles, Diego, Sreedharan, Rajasree, Rheault, Michelle N., Malatesta-Muncher, Rossana, Stone, Hillarey, Srivastava, Tarak, Kapur, Gaurav, Baddi, Poornima, Volovelsky, Oded, Pelletier, Jonathan, Gbadegesin, Rasheed, Seeherunvong, Wacharee, Patel, Hiren P., and Greenbaum, Larry A.
- Published
- 2019
- Full Text
- View/download PDF
5. The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study
- Author
-
Selewski, David T., Troost, Jonathan P., Massengill, Susan F., Gbadegesin, Rasheed A., Greenbaum, Larry A., Shatat, Ibrahim F., Cai, Yi, Kapur, Gaurav, Hebert, Diane, Somers, Michael J., Trachtman, Howard, Pais, Priya, Seifert, Michael E., Goebel, Jens, Sethna, Christine B., Mahan, John D., Gross, Heather E., Herreshoff, Emily, Liu, Yang, Song, Peter X., Reeve, Bryce B., DeWalt, Darren A., and Gipson, Debbie S.
- Published
- 2015
- Full Text
- View/download PDF
6. Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study
- Author
-
Selewski, David T., Massengill, Susan F., Troost, Jonathan P., Wickman, Larysa, Messer, Kassandra L., Herreshoff, Emily, Bowers, Corinna, Ferris, Maria E., Mahan, John D., Greenbaum, Larry A., MacHardy, Jackie, Kapur, Gaurav, Chand, Deepa H., Goebel, Jens, Barletta, Gina Marie, Geary, Denis, Kershaw, David B., Pan, Cynthia G., Gbadegesin, Rasheed, Hidalgo, Guillermo, Lane, Jerome C., Leiser, Jeffrey D., Song, Peter X., Thissen, David, Liu, Yang, Gross, Heather E., DeWalt, Darren A., and Gipson, Debbie S.
- Published
- 2014
- Full Text
- View/download PDF
7. Persistent Diarrhoea in Nigerian Children Aged Less Than Five Years: A Hospital-Based Study
- Author
-
Sodeinde, Olugbemiro, Adeyemo, Adebowale A, Gbadegesin, Rasheed A, and Ademowo, Olusegun G
- Published
- 1997
8. Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome.
- Author
-
Carpenter, Shannon L., Goldman, Jennifer, Sherman, Ashley K., Selewski, David T., Kallash, Mahmoud, Tran, Cheryl L., Seamon, Meredith, Katsoufis, Chryso, Ashoor, Isa, Hernandez, Joel, Supe-Markovina, Katarina, D'alessandri-Silva, Cynthia, DeJesus-Gonzalez, Nilka, Vasylyeva, Tetyana L., Formeck, Cassandra, Woll, Christopher, Gbadegesin, Rasheed, Geier, Pavel, Devarajan, Prasad, and Smoyer, William E.
- Subjects
STREPTOCOCCAL diseases ,THROMBOEMBOLISM risk factors ,HOSPITAL care of children ,CHILDREN'S hospitals ,HOSPITAL care ,LENGTH of stay in hospitals ,INTENSIVE care units ,LONGITUDINAL method ,NEPHROTIC syndrome ,STREPTOCOCCUS ,VEINS ,LOGISTIC regression analysis ,DISEASE prevalence ,MANN Whitney U Test ,DISEASE complications ,CHILDREN ,DISEASE risk factors - Abstract
Background: Nephrotic syndrome (NS) results in hypercoagulability and increased risk of infection. Furthermore, infection increases the risk of venous thromboembolism (VTE). Our objective was to determine the prevalence of infection, VTE, and the associated outcomes among a cohort of hospitalized children with NS.Methods: All children with NS admitted to 17 pediatric hospitals across North America from 2010 to 2012 were included. Prevalence of infection and VTE was determined. Wilcoxon rank-sum and logistic regression were performed.Results: Seven-hundred thirty hospitalizations occurred among 370 children with NS. One-hundred forty-eight children (40%) had ≥ 1 infection (211 episodes) and 11 (3%) had VTE. Those with VTE had infection more frequently (p = 0.046) and were younger at NS diagnosis (3.0 vs. 4.0 years; p = 0.008). The most common infectious pathogen identified was Streptococcus pneumoniae. The median hospital length of stay for those with infection [10 vs 5 days (p < 0.0001)] or VTE [22 vs 6 days (p < 0.0001)] was longer than those without either complication. Of those with infection, 13% had an intensive care unit (ICU) stay compared with 3.3% of those without infection. Median ICU stay was 4 days in those with VTE compared to 0 days in those without (p < 0.001). By logistic regression, only the number of ICU days was associated with VTE (OR 1.074, 95% CI 1.013-1.138).Conclusions: Hospitalized children with NS have high rates of infection. Presence of VTE was associated with infection. Both were associated with longer hospitalizations and ICU stays. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Enuresis in children and adolescents with sickle cell anaemia is more frequent and substantially different from the general population.
- Author
-
Esezobor, Christopher Imokhuede, Akintan, Patricia, Temiye, Edamisan, Akinsulie, Adebola, Nwaogazie, Uche, Akinwunmi, Edna, and Gbadegesin, Rasheed
- Subjects
ENURESIS ,SICKLE cell anemia ,ADULT-child relationships ,PRIMARY health care ,DEMOGRAPHIC surveys ,PATIENTS ,DISEASES ,CHARTS, diagrams, etc. ,DISEASE risk factors - Abstract
Background: No large studies have examined the prevalence of enuresis, its various forms and risk factors in children with sickle cell anaemia (SCA) in Sub-Saharan Africa using standardised definitions. We determined age and gender-specific prevalence of enuresis and compared the nature of enuresis in children with and without SCA. We also identified predictors of enuresis in children with SCA. Methods: Caregivers of children with SCA attending a tertiary centre haematology clinic in Nigeria were interviewed using a questionnaire. In addition, a separate questionnaire was completed for every sibling aged 5–17 years whose haemoglobin genotype was known. Enuresis and its various forms were defined using the definitions of the International Children’s Continence Society. Results: The study involved 243 children with SCA and 243 controls matched for age and sex. The mean age of the study cohort was 9.9 (3.4). Females made up 45.7% of the cohorts. The prevalence of enuresis was 49.4% and 29.6% in children with and without SCA, respectively (p = 0.009). In both groups, the prevalence of enuresis declined with age but remained five times higher at 25% in children with SCA aged 14–17 years compared with controls. Also, children with SCA and enuresis were older, more likely to have non-monosymptomatic enuresis and wet at least three nights per week than controls. Independent predictors of enuresis in children with SCA were a family history of enuresis and young age. Conclusion: Children with SCA had more frequent and more severe enuresis which persisted to late adolescence than age and sex-matched controls. These features indicate a subset of enuresis that is difficult to treat in the general population. Young age and enuresis in a family member define a subset of children with SCA more likely to have enuresis. Healthcare workers need to discuss enuresis with parents of children with SCA and offer referral to continence services. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.
- Author
-
Selewsk, David T., Troost, Jonathan P., Cummings, Danyelle, Massengill, Susan F., Gbadegesin, Rasheed A., Greenbaum, Larry A., Shatat, Ibrahim F., Yi Cai, Kapur, Gaurav, Hebert, Diane, Somers, Michael J., Trachtman, Howard, Pais, Priya, Seifert, Michael E., Goebel, Jens, Sethna, Christine B., Mahan, John D., Gross, Heather E., Herreshoff, Emily, and Yang Liu
- Subjects
NEPHROTIC syndrome in children ,INTERNAL medicine ,PEDIATRIC nephrology ,EDEMA ,COHORT analysis ,FATIGUE (Physiology) ,PAIN & psychology ,ANXIETY ,MENTAL depression ,NEPHROTIC syndrome ,COMPARATIVE studies ,HEALTH status indicators ,INTERPERSONAL relations ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,QUALITY of life ,QUESTIONNAIRES ,RESEARCH ,SELF-evaluation ,EVALUATION research ,STANDARDS ,PSYCHOLOGY - Abstract
Background: Nephrotic syndrome represents a condition in pediatric nephrology typified by a relapsing and remitting course, proteinuria and the presence of edema. The PROMIS measures have previously been studied and validated in cross-sectional studies of children with nephrotic syndrome. This study was designed to longitudinally validate the PROMIS measures in pediatric nephrotic syndrome.Methods: One hundred twenty seven children with nephrotic syndrome between the ages of 8 and 17 years participated in this prospective cohort study. Patients completed a baseline assessment while their nephrotic syndrome was active, a follow-up assessment at the time of their first complete proteinuria remission or study month 3 if no remission occurred, and a final assessment at study month 12. Participants completed six PROMIS measures (Mobility, Fatigue, Pain Interference, Depressive Symptoms, Anxiety, and Peer Relationships), the PedsQL version 4.0, and two global assessment of change items.Results: Disease status was classified at each assessment: nephrotic syndrome active in 100% at baseline, 33% at month 3, and 46% at month 12. The PROMIS domains of Mobility, Fatigue, Pain Interference, Depressive Symptoms, and Anxiety each showed a significant overall improvement over time (p < 0.001). When the PROMIS measures were compared to the patients' global assessment of change, the domains of Mobility, Fatigue, Pain Interference, and Anxiety consistently changed in an expected fashion. With the exception of Pain Interference, change in PROMIS domain scores did not correlate with changes in disease activity. PROMIS domain scores were moderately correlated with analogous PedsQL domain scores.Conclusion: This study demonstrates that the PROMIS Mobility, Fatigue, Pain Interference, and Anxiety domains are sensitive to self-reported changes in disease and overall health status over time in children with nephrotic syndrome. The lack of significant anchoring to clinically defined nephrotic syndrome disease active and remission status may highlight an opportunity to improve the measurement of HRQOL in children with nephrotic syndrome through the development of a nephrotic syndrome disease-specific HRQOL measure. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.